Dexcom, Inc.
Clinical trials sponsored by Dexcom, Inc., explained in plain language.
A medical device company specializing in continuous glucose monitoring systems for diabetes.
Trade on eToro (ad)Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
-
Could a simple monitor transform blood sugar control for millions with type 2 diabetes?
Disease control OngoingThis study tests whether using a continuous glucose monitor (CGM) helps adults with type 2 diabetes who do not take insulin improve their blood sugar control. Participants are randomly assigned to either use a real-time CGM or receive routine care with occasional blinded CGM wear…
Phase: NA • Sponsor: DexCom, Inc. • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Smart insulin dosing system aims to simplify diabetes management
Disease control OngoingThis study tests a system that combines a continuous glucose monitor (CGM) with daily insulin dose recommendations for people with type 2 diabetes who are starting basal insulin. Participants wear a Dexcom CGM sensor and receive suggested insulin doses through the DexBasal system…
Phase: PHASE1 • Sponsor: DexCom, Inc. • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Can a smart glucose monitor help type 2 diabetes patients on insulin?
Disease control OngoingThis study is testing whether a real-time continuous glucose monitor (CGM) can help 200 adults with type 2 diabetes who use insulin in Saudi Arabia. Participants wear a CGM device that tracks blood sugar levels continuously. The main goal is to see if it improves HbA1c, a measure…
Phase: PHASE4 • Sponsor: DexCom, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC